Lineage Cell Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.About LCTX
Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.
LCTX Key Statistics
Stock Snapshot
The current Lineage Cell Therapeutics(LCTX) stock price is $1.58, with a market capitalization of 374.88M. The stock trades at a price-to-earnings (P/E) ratio of -5.68.
On 2026-03-18, Lineage Cell Therapeutics(LCTX) stock traded between a low of $1.50 and a high of $1.65. Shares are currently priced at $1.58, which is +5.3% above the low and -4.2% below the high.
The Lineage Cell Therapeutics(LCTX)'s current trading volume is 932.36K, compared to an average daily volume of 1.39M.
During the past year, Lineage Cell Therapeutics(LCTX) stock moved between $0.37 at its lowest and $2.09 at its peak.
During the past year, Lineage Cell Therapeutics(LCTX) stock moved between $0.37 at its lowest and $2.09 at its peak.
LCTX News
New insider activity at Lineage Therap ( (LCTX) ) has taken place on March 12, 2026. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful in...
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.